Bausch Health Companies Inc. (BHC)

8,69 +0,09 (+1,05%) Al cierre: 04:00PM EDT

Bausch Health Companies Inc.

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
514 744 6792
https://www.bauschhealth.com

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 20.270

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Thomas J. Appio	CEO & Director	2,74M	N/A	1962
Mr. John S. Barresi	Senior VP, Controller, Chief Accounting Officer & Interim CFO	796,8k	N/A	1973
Ms. Seana Carson	Executive VP & General Counsel	872,65k	N/A	1973
Mr. Mirza Dautbegovic	Senior VP & COO	N/A	N/A	N/A
Mr. Josh Coyle	Senior Vice President of Sales & Salix	N/A	N/A	N/A
Ms. Kathleen Fitzpatrick	Senior VP & Chief HR Officer	N/A	N/A	N/A
Dr. Tage Ramakrishna M.D.	Chief Medical Officer and President of R&D	N/A	N/A	1974
Mr. Jeff Hartness	Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs	N/A	N/A	N/A
Dr. Graham Jackson	Senior VP & Chief Quality Officer	N/A	N/A	N/A
Mr. Cees Heiman	Senior Vice President of Europe & Canada	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Gobierno corporativo

El ISS Governance QualityScore de Bausch Health Companies Inc., a día 1 de abril de 2024, es 4. Las puntuaciones base son Auditoría: 5; Tablero: 2; Derechos de los accionistas: 3; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.